Misoprostol and the debate over off-label drug use

doi:10.1111/j.1471-0528.2004.00490.x

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Systems Maintenance, Monday, 15th February 2010

Wiley InterScience

BJOG: An International Journal of Obstetrics & Gynaecology

Volume 112 Issue 3, Pages 269 - 272

Published Online: 14 Dec 2004

Published on behalf of the Royal College of Obstetricians and Gynaecologists

Go to Society Site

< Previous Abstract | Next Abstract >

Save Article to My Profile Download Citation Request Permissions

Abstract | References | Full Text: HTML, PDF (Size: 61K) | Related Articles | Citation Tracking

COMMENTARY

Misoprostol and the debate over off-label drug use

Andrew D. Weeks ^a , Christian Fiala ^b , Peter Safar ^c

www.misoprostol.org
^a University of Liverpool, Liverpool Women's Hospital, UK
^b Gynmed Ambulatorium, Vienna, Austria
^c Department of Obstetrics and Gynaecology, General Public Hospital, Korneuburg, Austria